Press Release: RCBC BidCo Pty Ltd Announces Extension of Offer

Dow Jones
01 Feb

RCBC BidCo Pty Ltd Announces Extension of Offer

PR Newswire

PARK CITY, Utah, Jan. 31, 2025

PARK CITY, Utah, Jan. 31, 2025 /PRNewswire/ -- RCBC BidCo Pty Ltd ("BidCo") today announced the extension of its offer dated November 29, 2024 to acquire up to 100% of the ordinary shares of Parnell Pharmaceuticals Holdings Ltd ("Parnell") from existing Parnell shareholders (the "Offer").

In accordance with the terms of the Offer, BidCo is extending the expiration date of the Offer to 5:00pm Friday, 14 March 2025 (New York City time). The Offer was previously scheduled to expire on 5:00pm, 31 January 2025 (New York City time). All other terms and conditions of the Offer remain unchanged.

Completion of the Offer will now occur on or before Wednesday, 19 March 2025 (New York City time), unless the expiry date is further extended by BidCo.

As at the date of this announcement, 118,301,020 Parnell ordinary shares have accepted the Offer.

For questions about the Offer, please contact Georgeson, the Information Agent, toll-free at (866) 735 -- 8657 or +1 (781) 896-3676 (Monday through Friday 9 a.m. to 11 p.m. and Saturday 12 p.m. to 6 p.m. New York City time).

View original content:https://www.prnewswire.com/news-releases/rcbc-bidco-pty-ltd-announces-extension-of-offer-302365609.html

SOURCE RCBC BidCo

 

(END) Dow Jones Newswires

January 31, 2025 16:24 ET (21:24 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10